The noninvasive ventilation masks market size is projected to reach US$ 3.25 billion by 2031 from US$ 2.05 billion in 2023. The market is expected to register a CAGR of 5.9% during 2023–2031. The rising technological advancements in noninvasive ventilation masks are likely to act as a future trend in the market in the coming years.
Invasive ventilation methods are often avoided in COPD patients to reduce risks of complications such as infections and mechanical lung injuries. Noninvasive ventilation masks are preferred because they provide breathing support without requiring intubation. Thus, the chronic, long-term nature of COPD and sleep apnea leads to repeat purchases and creates a demand for NIV masks, thereby generating a steady, sustainable market for manufacturers.
According to the National Council on Aging, Inc. estimates, 39 million adults in the US had OSA in 2023. As per an article titled "What knows a frail Swiss population about chronic obstructive pulmonary disease?," about 400,000 people in Switzerland suffered from COPD in 2021. Noninvasive ventilation (NIV) is the administration of oxygen support through a face mask, eliminating the need for an endotracheal airway in the treatment of various conditions, including COPD, cardiogenic pulmonary edema, and other respiratory conditions without complications such as respiratory muscle weakness, upper airway trauma, and ventilator-associated pneumonia. Noninvasive ventilation masks can be reusable or disposable. The disposable noninvasive ventilation masks are for single use and are disposed off to reduce the risk of cross-contamination. Advances in mask design, comfort, durability, and the incorporation of skin-friendly materials can boost the adoption of NIV masks as patients look for more efficient and comfortable products. Thus, the adoption of NIV masks as an effective treatment of such prevalent respiratory conditions is expected to continue to boost the growth of the noninvasive ventilation masks market during 2023–2031.
A shift from long-term facilities, inpatient rehabilitation, and skilled nursing facilities to home care settings results in a better, consistent, and timely interaction between patient and doctor owing to the cloud and mobility-driven medical devices. The COVID-19 outbreak triggered home healthcare's importance due to limited hospital bed capacity and a scarcity of skilled healthcare professionals. With the help of home healthcare, healthcare professionals can monitor patient's vitals remotely and avoid hospital admissions.
Moreover, patients with conditions such as COPD, sleep apnea, and other respiratory issues are increasingly expressing a preference for at-home management of their ailments. Patients can use NIV therapy in the comfort of their homes without having to make frequent visits to the hospital. Home healthcare providers are prescribing NIV masks more frequently as a component of all-encompassing respiratory care plans.
Therefore, due to the growing traction toward home healthcare and increasing demand for more advanced, affordable, and easily navigable devices at home, the market for Noninvasive ventilation masks is gaining noticeable traction.
Noninvasive ventilation masks are becoming increasingly popular and expanding market opportunities by spurring innovation. Earlier diagnosis and treatment are being made possible by growing awareness campaigns about respiratory disorders such as COPD, sleep apnea, and others. The increased prescription and usage of NIV masks for disease management results from greater awareness among patients and healthcare professionals. Thus, emerging awareness of early diagnosis is likely to drive the adoption of NIV masks and create significant opportunities in the market. Moreover, respiratory illnesses are becoming more common in emerging economies, particularly in Asia Pacific, Latin America, and the Middle East, due to pollution, urbanization, and lifestyle changes. The noninvasive therapies are becoming widely known in these areas, owing to which the use of NIV masks is likely to continue to propel during the forecast period.
Key segments that contributed to the derivation of the noninvasive ventilation masks market analysis are product, application, and end user.
The geographic scope of the noninvasive ventilation masks market report is mainly divided into five regions: North America, Asia Pacific, Europe, South & Central America, and the Middle East & Africa. North America dominated the market in 2023. The US is the largest and fastest-growing market for noninvasive ventilation masks. According to the American Medical Association, ~30 million people in the US had sleep apnea in 2022; however, only 6 million were screened for this condition. In addition, ~14.8 million adults have been diagnosed with COPD in the same year, which is the fourth leading cause of death in the US. The growing prevalence of these chronic lung diseases is expected to increase the demand for NIV treatment options, boosting the growth of the noninvasive ventilation masks market in the US.
Furthermore, the presence of leading market players, such as Sleepnet Corporation, Philips, and Hamilton Medical, offering NIV masks and strategic developments by these market players in the US are expected to increase the noninvasive ventilation masks market share in the country during the forecast period. For instance, in August 2024, Sleepnet Corporation partnered with a renowned US pediatric hospital to introduce the Mini Me 2 NIV mask for studying the impact of innovative medical devices on patient care.
The regional trends and factors influencing the Noninvasive Ventilation Masks Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Noninvasive Ventilation Masks Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 2.05 Billion |
| Market Size by 2031 | US$ 3.25 Billion |
| Global CAGR (2023 - 2031) | 5.9% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Noninvasive Ventilation Masks Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Noninvasive Ventilation Masks Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The noninvasive ventilation masks market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
The "Noninvasive Ventilation Masks Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
The List of Companies - Noninvasive Ventilation Masks Market
The market is expected to register a CAGR of 5.9% during 2023–2031.
North America dominated the market in 2023.
The noninvasive ventilation masks market value is expected to reach US$ 3.25 billion by 2031.
The increasing prevalence of respiratory diseases and the growing inclination toward home healthcare are among the most significant factors fueling the market growth.
Hamilton Medical AG, ResMed Inc, Fisher & Paykel Healthcare Corp Ltd, Air Liquide Medical Systems, Dragerwerk AG & Co KGaA, Intersurgical Ltd, BMC Medical Co Ltd, DeVilbiss Healthcare LLC, Armstrong Medical Ltd, Koninklijke Philips NV, Besmed Health Business Corp, Sleepnet Corporation, SunMed Group Holdings LLC (AirLife), Dimar S.P.A., and Hangzhou Formed Medical Devices Co., Ltd are among the key players in the market.
Technological advancements in noninvasive ventilation masks are expected to emerge as a prime trend in the market in the coming years.